Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The woman has had an undetectable viral load and a normal CD4 count for more than 12 years after stopping antiretroviral therapy.
Middle-aged Black adults living with HIV reported substantial economic impact of COVID-19 and high medical mistrust.
A new CDC model shows the potential power of Undetectable = Untransmittable to curb HIV rates by 2027.
Injectable cabotegravir and rilpivirine are approved for people with viral suppression who would prefer monthly injections to daily pills.
People with HIV and ulcerative colitis or Crohn’s disease may need less IBD medication and have fewer hospitalizations.
The 1917 Clinic has offered HIV services in Birmingham, Alabama, since 1988.
COVID-19, HIV vaccines, cure news and long-acting injectables stood out among the top HIV treatment stories of the year.
No one has reported health problems from the counterfeit HIV med Symtuza. Here’s how drugmaker Janssen wants to ensure patient safety.
The European Medicines Agency gave the green light to injectable cabotegravir and rilpivirine for HIV treatment.
HIVMA updated its 2013 guidance on providing evidence-based primary care to people with HIV.
Here are the researchers who will lead the four networks of HIV trials and what each network will focus on.
These two integrase inhibitors are associated with high blood sugar and diabetes.
Extended follow-up confirms that the long-acting monoclonal antibody works well for people with highly resistant HIV.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.